Efficacy and Safety of Ayurveda Intervention AYUSH 64 as add-on therapy for patients with COVID 19 infections: An open labelled, Parallel Group, Randomized controlled clinical trial
Bhardwaj, P.; Godatwar, P. K.; Charan, J.; Sharma, S.; Shafi, S.; Chauhan, N.; Vyas, P.; Dutt, N.; Midha, N.; Jalandra, R.; Sharma, M.; Nag, V. L.; Sharma, S.; Singh, S. K.; Sharma, P.; Misra, S.
Show abstract
The authors have withdrawn this manuscript because they found a serious issue in data-analysis which leads to wrong interpretation of the results. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Efficacy and safety of Mojeaga remedy in combination with conventional oral iron therapy for correcting anemia in obstetric population: a phase II randomized pilot clinical trial 97%
- Antioxidant enriched fraction from Pueraria tuberosa alleviates ovariectomized-induced osteoporosis in rats, and inhibits growth of breast and ovarian cancer cell lines in vitro 96%
- Health-Related Quality of Life and Coping Strategies adopted by COVID-19 survivors: A nationwide cross-sectional study in Bangladesh 95%
Similar papers in this journal
- A Novel Maxillofacial Technology for Drug Administration-A Randomized Controlled Trial Using Metronidazole. 96%
- Comparative study between first and second wave of COVID-19 deaths in India - a single center study 96%
- Clearing the fog: Is Hydroxychloroquine effective in reducing Corona virus disease-2019 progression: A randomized controlled trial 95%
Similar papers in this journal
- Experience from a COVID-19 screening centre of a tertiary care institution: A retrospective hospital-based study 95%
- Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study 95%
- Prevalence and effect of bacterial co-infections on clinical outcomes in hospitalized COVID-19 patients at a tertiary care centre of India 95%
Similar papers in this journal
- Risk Factors for Non-Communicable Diseases among Bangladeshi Adults: An Application of Generalized Linear Mixed Model on Multilevel Demographic and Health Survey Data 95%
- Incidences of poor-quality pharmaceutical products in Nepal 94%
- Protocol for a prospective, hospital-based registry of pregnant women with SARS-CoV-2 infection in India: PregCovid Registry study 94%
Similar papers in this journal
- Randomized, double blind, placebo controlled, clinical trial to study co-administration of Ashwagandha on safety, immunogenicity, and protection with COVID-19 vaccine – A Study Protocol 95%
- Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial 95%
- Comprehensive assessment of Age-Specific Mortality Rate and its incremental changes using a composite measure: A sub-national analysis of rural Indian women 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.